What is CVE-2017-12714?

CVE-2017-12714 is a medium-severity vulnerability in Abbott Accent, classified under Improper Restriction of Power Consumption. CVSS score: 6.5/10. Published 2018-04-25.

How severe is CVE-2017-12714?

Medium severity. CVSS v3 base score is 6.5 out of 10.

Vulnerability in Abbott Accent

CVE-2017-12714

Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly formatted "RF wake-up" commands that can be received, which may allow a nearby attacker to repeatedly send commands to reduce pacemaker battery life. CVSS v3 base score: 5.3, CVSS vector string: AV:A/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H. Abbott has developed a firmware update to help mitigate the identified vulnerabilities.

Published 2018-04-25 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H.

EPSS exploit prediction

EPSS: 0.006 (49.0th percentile), scored 2026-09-30.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 49th percentile — 49.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.007 · newest: 0.006 · change: -0.000

Affected products

Weakness classification (CWE)

CWE-920 — Improper Restriction of Power Consumption

References

ics-cert.us-cert.gov/advisories/ICSMA-17-241-01 (US Government Resource, Third Party Advisory)
www.securityfocus.com/bid/100523 (VDB Entry, Third Party Advisory, vdb-entry)

Frequently asked questions

What is CVE-2017-12714?: CVE-2017-12714 is a medium-severity vulnerability in Abbott Accent, classified under Improper Restriction of Power Consumption. CVSS score: 6.5/10. Published 2018-04-25.
How severe is CVE-2017-12714?: Medium severity. CVSS v3 base score is 6.5 out of 10.